Sphingosine 1‐phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis
暂无分享,去创建一个
O. Volpert | J. Garcia | D. Brindley | Joe G. N. Garcia | D. English | A. T. Kovala | Z. Welch | K. Harvey | Zachary R. Welch
[1] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[2] J. P. Hobson,et al. Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor , 1999, The Journal of Biological Chemistry.
[3] Denis K. English,et al. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. , 1999, Journal of hematotherapy & stem cell research.
[4] K. Claffey,et al. Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate , 1999, Cell.
[5] R. Strieter,et al. Tumor angiogenesis is regulated by CXC chemokines. , 1998, The Journal of laboratory and clinical medicine.
[6] R. Gamelli,et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. , 1998, The American journal of pathology.
[7] S. Spiegel,et al. Sphingosine‐1‐Phosphate in Cell Growth and Cell Death a , 1998, Annals of the New York Academy of Sciences.
[8] C. H. Liu,et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.
[9] Ingrid,et al. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. , 1998, The Biochemical journal.
[10] R. Siddiqui,et al. Phosphatidic acid elicits calcium mobilization and actin polymerization through a tyrosine kinase-dependent process in human neutrophils: a mechanism for induction of chemotaxis. , 1997, Biochimica et biophysica acta.
[11] M. Dewhirst,et al. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. , 1997, The Journal of clinical investigation.
[12] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[13] A. Gomez-Muñoz,et al. Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts , 1997, Oncogene.
[14] O. Kranenburg,et al. Lysophosphatidic acid: G-protein signalling and cellular responses. , 1997, Current opinion in cell biology.
[15] E. Abel. Clinical applications of research on angiogenesis , 1996 .
[16] J. Folkman,et al. A model of angiogenesis in the mouse cornea. , 1996, Investigative ophthalmology & visual science.
[17] M. Rusnati,et al. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans , 1996, International journal of clinical & laboratory research.
[18] S. Hakomori,et al. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. , 1995, Blood.
[19] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[20] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[21] J. Richie,et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.
[22] A. Ullrich,et al. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.
[23] I. Fahrenfort,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.
[24] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[25] A. Yayon,et al. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. , 1993, Journal of the National Cancer Institute.
[26] R. Miledi,et al. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. , 1992, The Journal of biological chemistry.
[27] A. Passaniti,et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[28] S. Spiegel,et al. Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines. , 1991, Biochemical and biophysical research communications.
[29] T. Hla,et al. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. , 1990, The Journal of biological chemistry.
[30] J. Gerrard,et al. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. , 1989, Biochimica et biophysica acta.